Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dalong Zhu

Showing results (141-150 of 207) with videos related to

Pageof 21
Sort By:
Renal Failure|November 16, 2016
Establishment and observation of a new and ideal reversible model of PUUOWei Zhu, Xi Zheng, Chunming Jiang, et al.
Journal of Endocrinological Investigation|June 26, 2014
Hyperglycemia and duration of diabetes as risk factors for abnormal lipids: a cross sectional survey of 19,757 patients with type 2 diabetes in ChinaLinong Ji, Jianping Weng, Juming Lu, et al.
Plos One|August 15, 2014
Hyperglycemia and blood pressure treatment goal: a cross sectional survey of 18350 patients with type 2 diabetes in 77 tertiary hospitals in ChinaLinong Ji, Xinyue Zhi, Juming Lu, et al.
Protein Expression and Purification|May 30, 2008
Expression, purification, and initial characterization of human alanine aminotransferase (ALT) isoenzyme 1 and 2 in High-five insect cellsLi Liu, Shao Zhong, Rongze Yang, et al.
Diabetes, Obesity & Metabolism|July 26, 2017
Efficacy and safety of lixisenatide in a predominantly Asian population with type 2 diabetes insufficiently controlled with basal insulin: The GetGoal-L-C randomized trialWenying Yang, Kyungwan Min, Zhiguang Zhou, et al.
Hypertension (Dallas, Tex. : 1979)|January 22, 2026
Efficacy and Safety of Finerenone in Patients With Primary Aldosteronism: A Multicenter Prospective StudyPing Li, Fan Yang, Yuxing Lou, et al.
Diabetes, Obesity & Metabolism|May 25, 2019
Glycaemic benefit of iGlarLixi in insulin-naive type 2 diabetes patients with high HbA1c or those with inadequate glycaemic control on two oral antihyperglycaemic drugs in the LixiLan-O randomized trialMelanie J Davies, David Russell-Jones, Thomas M Barber, et al.
Acta Diabetologica|August 15, 2014
Effects of exenatide, insulin, and pioglitazone on liver fat content and body fat distributions in drug-naive subjects with type 2 diabetesYan Bi, Bing Zhang, Wen Xu, et al.
Diabetologia|December 24, 2013
Role for sterol regulatory element binding protein-1c activation in mediating skeletal muscle insulin resistance via repression of rat insulin receptor substrate-1 transcriptionYan Bi, Wenjun Wu, Junfeng Shi, et al.
Diabetes/Metabolism Research and Reviews|July 25, 2023
Prevalence and risk factors of diabetic peripheral neuropathy: A population-based cross-sectional study in ChinaWeimin Wang, Qiuhe Ji, Xinwu Ran, et al.
Pageof 21

Showing results (141-150 of 207) with videos related to

Sort By:
Pageof 21
Renal Failure|November 16, 2016
Establishment and observation of a new and ideal reversible model of PUUOWei Zhu, Xi Zheng, Chunming Jiang, et al.
Journal of Endocrinological Investigation|June 26, 2014
Hyperglycemia and duration of diabetes as risk factors for abnormal lipids: a cross sectional survey of 19,757 patients with type 2 diabetes in ChinaLinong Ji, Jianping Weng, Juming Lu, et al.
Plos One|August 15, 2014
Hyperglycemia and blood pressure treatment goal: a cross sectional survey of 18350 patients with type 2 diabetes in 77 tertiary hospitals in ChinaLinong Ji, Xinyue Zhi, Juming Lu, et al.
Protein Expression and Purification|May 30, 2008
Expression, purification, and initial characterization of human alanine aminotransferase (ALT) isoenzyme 1 and 2 in High-five insect cellsLi Liu, Shao Zhong, Rongze Yang, et al.
Diabetes, Obesity & Metabolism|July 26, 2017
Efficacy and safety of lixisenatide in a predominantly Asian population with type 2 diabetes insufficiently controlled with basal insulin: The GetGoal-L-C randomized trialWenying Yang, Kyungwan Min, Zhiguang Zhou, et al.
Hypertension (Dallas, Tex. : 1979)|January 22, 2026
Efficacy and Safety of Finerenone in Patients With Primary Aldosteronism: A Multicenter Prospective StudyPing Li, Fan Yang, Yuxing Lou, et al.
Diabetes, Obesity & Metabolism|May 25, 2019
Glycaemic benefit of iGlarLixi in insulin-naive type 2 diabetes patients with high HbA1c or those with inadequate glycaemic control on two oral antihyperglycaemic drugs in the LixiLan-O randomized trialMelanie J Davies, David Russell-Jones, Thomas M Barber, et al.
Acta Diabetologica|August 15, 2014
Effects of exenatide, insulin, and pioglitazone on liver fat content and body fat distributions in drug-naive subjects with type 2 diabetesYan Bi, Bing Zhang, Wen Xu, et al.
Diabetologia|December 24, 2013
Role for sterol regulatory element binding protein-1c activation in mediating skeletal muscle insulin resistance via repression of rat insulin receptor substrate-1 transcriptionYan Bi, Wenjun Wu, Junfeng Shi, et al.
Diabetes/Metabolism Research and Reviews|July 25, 2023
Prevalence and risk factors of diabetic peripheral neuropathy: A population-based cross-sectional study in ChinaWeimin Wang, Qiuhe Ji, Xinwu Ran, et al.
Pageof 21